Award
Delivery Order #HT942726FE020
Leidos Awarded Delivery Order for Breast Cancer Research Support
Buyer
Defense Health Agency
Award Amount
$631,610.06
Ceiling
$631,610.06
Awarded
May 16, 2026
Period of Performance
May 16, 2026 – Mar 31, 2027
Identifier
HT942726FE020
NAICS
541990
This award represents a delivery order contract under a broader indefinite delivery vehicle focused on supporting breast cancer research programs. The recipient, Leidos, Inc., a leading defense and technology services company, is tasked with providing specialized research support services instrumental to advancing breast cancer studies. The contract underscores the agency's dedication to health-related research initiatives with potential far-reaching impacts on public health and medical communities. Scope of work includes delivering targeted research assistance and administrative facilitation critical to program success. The award follows a competitive acquisition strategy within the structured framework of an existing multi-year contract for programmatic and administrative support, indicating a streamlined procurement approach. Key milestones include the recent award and an active performance period extending over several months into the next year, emphasizing ongoing commitment to the research objectives.
Description
BREAST CANCER RESEARCH PROGRAM